Browsing Tag

AVT02

Alvotech and Bioventure Announce Approval of AVT02 (adalimumab) as Simlandi in Saudi…

Dustin Moskovitz Jan 24, 2023 0

AVT02 as Simlandi™ is the first biosimilar approved under the strategic partnership between Alvotech and Bioventure Alvotech (NASDAQ: ALVO) and Bioventure, a wholly owned subsidiary of…

Health

Alvotech og Bioventure fá markaðsleyfi fyrir AVT02 (adalimumab) í Sádi-Arabíu

Eli Pacheco Jan 24, 2023 0

Alvotech (NASDAQ: ALVO) og Bioventure, dótturfyrirtæki GlobalOne Healthcare Holding LLC, heilbrigðissviðs YAS Holding LLC, tilkynntu í dag að lyfja- og matvælaeftirlit Sádi-Arabíu (SFDA)…

Health

Alvotech Announces Australian Marketing Authorization for AVT02, a Biosimilar to…

Eli Pacheco Nov 14, 2022 0

Increases availability of cost-effective high-concentration low-volume adalimumab in AustraliaFirst approved biosimilar from the partnership with Cipla, which also includes four other…